Rheumatic Diseases Research Resource-Based Center

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Natural Killer Cells 72%
3. Macrophages 60%
4. Osteoclasts 56%
5. Genes 49%
6. Dendritic Cells 49%
7. Bone and Bones 47%
8. Proteins 43%
9. West Nile virus 42%
10. Neoplasms 41%
11. B-Lymphocytes 40%
12. Infections 40%
13. Peptides 37%
14. Cytokines 35%
15. Non-Small Cell Lung Carcinoma 35%
16. Mutation 34%
17. Lymphocytes 33%
18. Interferons 33%
19. Ligands 33%
20. Antibodies 31%
21. Neutrophils 30%
22. Therapeutics 30%
23. Antigens 29%
24. West Nile Fever 29%
25. Monoclonal Antibodies 28%
26. Cartilage 28%
27. Virus Diseases 27%
28. Inflammation 26%
29. In Vitro Techniques 26%
30. Phenotype 25%
31. Viruses 25%
32. Coronavirus 25%
33. Immunity 25%
34. Membrane Cofactor Protein 25%
35. Myeloid Cells 24%
36. Chronic Granulomatous Disease 24%
37. Interferon Type I 23%
38. Chondrocytes 23%
39. Natural Killer Cell Receptors 22%
40. Interleukin-1 22%
41. Lung 22%
42. Osteoblasts 22%
43. Messenger RNA 22%
44. Articular Cartilage 22%
45. Osteoarthritis 22%
46. Epitopes 21%
47. SARS Virus 21%
48. Gene Expression 21%
49. NADPH Oxidases 20%
50. Ocular Hypertension 20%
51. Antiviral Agents 20%
52. Joints 20%
53. Osteogenesis 20%
54. Bone Marrow 20%
55. Monocytes 20%
56. Dengue Virus 20%
57. Integrins 19%
58. Innate Immunity 19%
59. Severe Acute Respiratory Syndrome 19%
60. Homeostasis 19%
61. Wounds and Injuries 19%
62. Zika Virus 19%
63. Complement Activation 19%
64. Population 19%
65. Antigen Presentation 18%
66. Global Burden of Disease 18%
67. Phagocytes 18%
68. Apolipoproteins B 18%
69. Stem Cells 18%
70. Transcription Factors 17%
71. Complement System Proteins 17%
72. Major Histocompatibility Complex 17%
73. Interleukin-12 16%
74. Bone Resorption 16%
75. Flavivirus 16%
76. Regulatory T-Lymphocytes 16%
77. Arthritis 16%
78. Epithelial Cells 16%
79. T-Cell Antigen Receptor 15%
80. Membranes 15%
81. Lung Neoplasms 15%
82. Vaccines 15%
83. Serum 15%
84. hen egg lysozyme 15%
85. Liver 15%
86. Chikungunya virus 14%
87. Calcium 14%
88. Meniscus 14%
89. Occupational Groups 14%
90. Neutralizing Antibodies 13%
91. Genome 13%
92. RNA 13%
93. Complement Receptors 13%
94. Survival 13%
95. 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one 13%
96. Immune System 13%
97. Twin Studies 13%
98. Carpal Tunnel Syndrome 13%
99. Veterans 13%
100. Histocompatibility Antigens Class II 13%